Conv. Plasma
Nigella Sativa
Peg.. Lambda

All vitamin D studies
Meta analysis
Home COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  

The Role of Free Vitamin D and Vitamin D Binding Protein in SARS-Cov-2 Infection in Children

Us et al., Research Square, doi:10.21203/, NCT05598957
Mar 2023  
  Source   PDF   All Studies   Meta AnalysisMeta
Prospective study of 82 pediatric patients in Turkey, showing symptom severity associated with free vitamin D and bioavailable vitamin D levels.
Us et al., 28 Mar 2023, prospective, Turkey, preprint, 7 authors, trial NCT05598957 (history).
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
The Role of Free Vitamin D and Vitamin D Binding Protein in SARS-Cov-2 Infection in Children
Mahmut Caner Us, Aslı Devrim Lanpir, Şükran Özdatlı Kurtuluş, Mesut Yağcı, Özlem Akarsu, Kamil Şahin, Gülşen Akkoç
Purpose: Many studies have discussed the effects of serum vitamin D de ciency in SARS-CoV-2 patients. This study aimed to investigate the relationship between SARS-CoV-2 infection severity and free vitamin D (FVD) and bioavailable vitamin D (BAVD) levels in children. Methods: A prospective case-control study design was used. Participants were divided into three groups based on the World Health Organization (WHO) COVID-19 Clinical Progression Scale. Serum 25-hydroxyvitamin D (25OH vitamin D; ng/mL), albumin (g/L), and vitamin D binding protein (ng/mL) levels were evaluated to investigate the relationship between disease severity and FVD and BAVD levels. Results: In total, 82 participants were included in the study. Of those, 24.4 % were uninfected (n = 20), 50% had a mild case of SARSS-CoV-2 (n = 41), and 25.6% had a moderate case (n = 21). There was a statistically signi cant difference in FVD and BAVD levels between the groups (p = 0.026). Median FVD (p = 0.007, Cohen's d = 0.84) and BAVD (p = 0.007, Cohen's d = 0.86) levels were signi cantly higher in the mild group compared to the moderate group. FVD and BAVD metabolites were moderately positively correlated with lymphocyte counts (FVD: r = 0.437, p < 0.001; BAVD: r = 0.439, p < 0.001). Conclusion: This is the rst study to demonstrate a relationship between SARS-CoV-2 symptom severity and FVD and BAVD levels. The relationship between FVD and BAVD levels and lymphocyte counts could play an important role in symptom severity and should be evaluated in further studies. The study was registered with Clinical Trials (NCT05598957, 10/06/2022).
Declarations Acknowledgement: Authors thanks to all patients and their families Competing Interests: The authors have no relevant nancial or non-nancial interests to disclose. Author Contributions: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Mahmut Caner Us, Gülşen Akkoç, Şükran Özdatli Kurtuluş, Mesut Yagci, Aslı Devrim Lanpir, Özlem Akarsu. The rst draft of the manuscript was written by Mahmut Caner Us, Gülşen Akkoç, Kamil Şahin and all authors commented on previous versions of the manuscript. All authors read and approved the nal manuscript. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the TC Health Sciences University Hamidiye Clinical Ethics Committee with protocol decision numbered 2022/10/17 and registered with Clinical Trials (NCT05598957, 10/06/2022). Consent to participate: Written informed consent was obtained from the parents. Consent to publish: participants con rmed and signed the informed consent form to the publication of the study. Congresses: This paper was presented as oral presentation at the Social Pediatric Society of Turkey's in the selected abstracts of the 3th International Eurasian Social Pediatric congress organized in İzmir (Turkey) between November 16th-20th 2022. "SS-006"
Alpcan, Tursun, Kandur, Vitamin D levels in children with COVID-19: a report from Turkey, Epidemiol. Infect
Bayramoğlu, The association between vitamin D levels and the clinical severity and in ammation markers in pediatric COVID-19 patients: singlecenter experience from a pandemic hospital, Eur. J. Pediatr
Bikle, Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein, J. Clin. Endocrinol. Metab
Chun, Vitamin D-binding protein directs monocyte responses to 25-hydroxy-and 1,25-dihydroxyvitamin D, J. Clin. Endocrinol. Metab
D'avolio, Vitamin D de ciency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19, J. Endocrinol. Invest
Dancer, Vitamin D de ciency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax
Del Giudice, Vitamin D status can affect COVID-19 outcomes also in pediatric population, PharmaNutrition
Grant, Evidence that Vitamin D Supplementation Could Reduce Risk of In uenza and COVID-19 and Deaths, Nutrients
Group, A minimal common outcome measure set for COVID-19 clinical research, Lancet Infect. Dis
Hewison, Vitamin D and the intracrinology of innate immunity, Mol. Cell. Endocrinol
Hurst, Vitamin D insu ciency in COVID-19 and in uenza A, and critical illness survivors: a cross-sectional study, BMJ Open
Jeng, Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis, J. Transl Med
Kaufman, SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels, PLoS One
Kazemi, Association of Vitamin D Status with SARS-CoV-2 Infection or COVID-19 Severity: A Systematic Review and Meta-analysis, Adv. Nutr
Meltzer, Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results, JAMA Netw. Open
Mendel, The free hormone hypothesis: a physiologically based mathematical model, Endocr. Rev
Nair, Maseeh, Vitamin, The "sunshine" vitamin, J. Pharmacol. Pharmacother
Papadimitriou, Vassaras, Holick, Association between population vitamin D status and SARS-CoV-2 related serious-critical illness and deaths: An ecological integrative approach, World J. Virol
Shah, Low vitamin D levels and prognosis in a COVID-19 pediatric population: a systematic review, Qjm
Speeckaert, Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism, Clin. Chim. Acta
Speeckaert, De Buyzere, Delanghe, Vitamin D binding protein polymorphism and COVID-19, J. Med. Virol
Speeckaert, Speeckaert, Delanghe, Genetic polymorphisms, vitamin D binding protein and vitamin D de ciency in COVID-19, Eur Respir J
Speeckaert, Speeckaert, Delanghe, Vitamin D Su ciency and COVID-19: Is Vitamin D Binding Protein (and Its Polymorphism) the Missing Link?, Endocr. Pract
Subramanian, Vitamin D, vitamin D-binding protein, free vitamin D and COVID-19 mortality in hospitalized patients, Am. J. Clin. Nutr
Vasheghani, Rekabi, Sadr, Protective role of vitamin D status against COVID-19: a mini-review, Endocrine
Vermeulen, Verdonck, Kaufman, A critical evaluation of simple methods for the estimation of free testosterone in serum, J. Clin. Endocrinol. Metab
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop